You are here

Mydecine Innovations Group Inc.

Listing Exchange: 
CSE
Status: 
Delisted
Industry: 
Life Sciences
Symbol: 
MYCO
CSE Index: 
Currency: 

Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

You are here

Mydecine Innovations Group Inc. (MYCO)

SEDAR Information

Company Info

Address
789 W Pender Street, Suite 810
Vancouver, BC V6C 1H2
Canada
Phone
604-687-2038
Email
contact@mydecineinc.com
Website
http://www.mydecineinc.com
Listing date
Monday, August 18, 2014
Transfer Agent
National Securities Administrators Ltd.
Investor Relations
D. Joshua Bartch
Email
contact@mydecineinc.com
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
227,275,407
Reserved for Issuance: 
52,748,136

Bulletins

19/03/2021

2021-0332 - Delist - Mydecine Innovations Group Inc. (MYCO, MYCO.WT)

le 22 mars/March 2021

At the request of the company the common shares and warrants of Mydecine Innovations Group Inc.  will be delisted at market close on March 22, 2021.

The Company’s common shares will continue to trade on NEO Stock Exchange.

For further information please see the issuer’s press release.

________________________________

Advertisement

Publicité

Latest CSE News

Upcoming Events